Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.489NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.363NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.363NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.363NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.95NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.95NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.95NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.531NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.531NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.531NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.200NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.200NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.200NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.299NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.299NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.299NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.149NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.149NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.149NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.300NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-18362.1US
B.1.1.300NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.300NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-19399.7China
B.1.179NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.179NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.179NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.125NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.125NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.125NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
G.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
G.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
G.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.438NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.438NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.438NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used